This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

The week’s remaining deals came from small Asian issuers, led by Chinese supply chain management firm Majestic Ideal Holdings ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S. initial public ...

The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

Klarna, the specialty lending and online payments provider, has halted its planned initial public offering, the latest IPO casualty in the wake of the Trump administration’s sweeping tariff ...

IPO fundraising in the U.K. market fell to at least a 30-year low in the first half of this year, according to data from Dealogic.